← Back to Screener
M Evo Global Acquisition Corp II Units (MEVOU)
Price$10.10
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (4W)0.62%
VGM Score29.56
Market Capitalization$298.20M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-7.93%
10-Day Avg Trading Volume0.02M
EPS (Annual)$-0.00
ROA (Last FY)-20.83%
Cash Flow / Share (Annual)$0.00
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)0.11x
3-Month Avg Trading Volume0.04M
52-Week High$9.95
EPS Excl Extra (Annual)$-0.00
Quick Ratio (Annual)0.11x
EPS Basic Excl Extra (Annual)$-0.00
Revenue / Share (Annual)$0.00
Year-to-Date Return0.81%
5-Day Price Return-0.05%
EPS Normalized (Annual)$-0.00
Month-to-Date Return-0.05%
EBITD / Share (Annual)$-0.00
Beta0.03x
52-Week Low$9.83
mGradeD
vgmGradeD
Show chart for
Industry Peers — Blank Checks / SPACs(773)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MEVOUM Evo Global Acquisition Corp II Units | — | — | D | $10.10 |
| KCAC.WSKensington Capital Acquisition Corp. VI Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 | F | A | A | $0.52 |
| WLACWillow Lane Acquisition Corp. Class A Ordinary Shares | — | C | A | $35.95 |
| CAEPCantor Equity Partners III, Inc. Class A Ordinary Shares | — | — | F | $6.90 |
| AACIUArmada Acquisition Corp. III Units | — | A | D | $10.08 |
| BACQRInflection Point Acquisition Corp. IV Right | — | D | D | $0.00 |
| BACQUInflection Point Acquisition Corp. IV Unit | — | D | D | $0.00 |
| AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | D | $9.95 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.08 |
| DMIIRDrugs Made In America Acquisition II Corp. Right | — | — | C | $0.08 |
| DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | C | $10.15 |
About
M Evo Global Acquisition Corp II is a special purpose acquisition company (SPAC) organized to identify and acquire a private business. The company raises capital through a public offering with the objective of completing a merger or acquisition that will create a publicly traded company.